1. Cif-Ii Scheme I 2. Creaegis II Vcc 3. Creaegis Investments Pcc Cell CH1
CCIC-2025/12/1357
A compact analysis
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
¶1
Summary in terms of Regulation 13(2) of the Competition Commission of India (Combinations) Regulations, 2024
¶2
- A. Parties to the combination are:
¶3
Acquirers
¶4
- CIF-II Scheme I (“ CIF-II ”);
¶6
- Creaegis II VCC (“ Creaegis II ”); and
¶7
- Creaegis Investments PCC Cell CH1 (“ Creaegis Investments ”)
¶8
- Hereinafter, CIF-II, Creaegis II and Creaegis Investments are collectively referred to as the “ Acquirers ”:
¶9
Target
¶10
- Boston Ivy Healthcare Solutions Private Limited (“ Target ”)
¶11
- Hereinafter, the Acquirers and the Target are collectively referred to as the “ Parties ”.
Case details
As recorded by the court registry
Similar cases
Judgements on the same questions, provisions and authorities, from every court